DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/lrgrtv/corporate) has announced the addition of the "Corporate Reputation of the Major Pharma Companies in Germany - from a Patient Perspective" report to their offering.
Ratings of corporate reputation of pharma and companies in the market - from a patient perspective
During November-December 2012, the author surveyed 600 international, national, regional (and a few local) patient groupsincluding 70 patient organisations based in Germany. We asked them for their opinions on the corporate reputation of pharma in general, and about 29 leading pharma companies in particular. The author published the results of this survey of 600 patient groups in January 2013 in The Corporate Reputation of Pharmathe Patient Perspective'.
Following on from the January 2013 publication, PatientView is releasing a series of reports considering the performance of major pharma companies in individual countries.
This present April 2013 report focuses on the corporate reputation of 15 pharma companies in Germany (and also compares the performance of each company with the results from the multi-national study). The German report draws on the views of the 70 German patient organisations which took part in the November-December 2012 survey.
Companies Mentioned
- Abbott {ABBVie]
- AstraZeneca
- Bayer
- Boehringer Ingelheim
- Bristol-Myers Squibb (BMS)
- Eli Lilly (Lilly)
- GlaxoSmithKline (GSK)
- Janssen
- Merck & Co [the US company]
- Merck Group [the German company]
- Novartis
- Pfizer
- Roche
- Sanofi
- Stada Arzneimittel
For more information visit http://www.researchandmarkets.com/research/lrgrtv/corporate
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
